ATE274349T1 - Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs - Google Patents
Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebsInfo
- Publication number
- ATE274349T1 ATE274349T1 AT98924315T AT98924315T ATE274349T1 AT E274349 T1 ATE274349 T1 AT E274349T1 AT 98924315 T AT98924315 T AT 98924315T AT 98924315 T AT98924315 T AT 98924315T AT E274349 T1 ATE274349 T1 AT E274349T1
- Authority
- AT
- Austria
- Prior art keywords
- prevention
- treatment
- colon cancer
- fructane
- production
- Prior art date
Links
- 206010009944 Colon cancer Diseases 0.000 title abstract 3
- 208000029742 colonic neoplasm Diseases 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 241000283690 Bos taurus Species 0.000 abstract 2
- 229920002670 Fructan Polymers 0.000 abstract 2
- 241000282414 Homo sapiens Species 0.000 abstract 2
- 229920001202 Inulin Polymers 0.000 abstract 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 2
- 229940029339 inulin Drugs 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000013376 functional food Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
- A23L29/055—Organic compounds containing sulfur as heteroatom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97870069A EP0879600A1 (de) | 1997-05-20 | 1997-05-20 | Fruktan-haltige Zusammensetzung zur Vorbeugung und Behandlung von Dickdarmkrebs |
| PCT/EP1998/002864 WO1998052578A1 (en) | 1997-05-20 | 1998-05-14 | Fructan containing composition for the prevention and treatment of colon cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE274349T1 true ATE274349T1 (de) | 2004-09-15 |
Family
ID=8231000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98924315T ATE274349T1 (de) | 1997-05-20 | 1998-05-14 | Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6500805B2 (de) |
| EP (2) | EP0879600A1 (de) |
| JP (2) | JP2001526671A (de) |
| KR (1) | KR100529271B1 (de) |
| CN (1) | CN1177593C (de) |
| AT (1) | ATE274349T1 (de) |
| AU (1) | AU7654898A (de) |
| CA (1) | CA2290482C (de) |
| DE (1) | DE69825887T3 (de) |
| DK (1) | DK0983072T4 (de) |
| ES (1) | ES2223130T5 (de) |
| ID (1) | ID23441A (de) |
| WO (1) | WO1998052578A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952033A (en) * | 1996-12-24 | 1999-09-14 | Nestec S.A. | Gelatinized cereal product containing oligosaccharide and processes of preparing and using same |
| NL1012300C2 (nl) * | 1999-06-11 | 2000-12-12 | Rijksuniversiteit | Stabilisator voor farmaca. |
| DE10006086A1 (de) * | 2000-02-11 | 2001-08-23 | Albert Kloeti | Hundegetränk |
| EP1125507A1 (de) | 2000-02-15 | 2001-08-22 | Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) | Inulinprodukte mit verbesserten Nahrungseigenschaften |
| US7431939B1 (en) * | 2000-09-28 | 2008-10-07 | Mississippi State University | Inhibition of systemic infections in humans and vertebrates by dietary fibers |
| AU2002332318B2 (en) | 2001-09-26 | 2007-09-13 | Fuji Nihon Seito Corporation | Process for producing inulin |
| US20040001898A1 (en) * | 2002-06-26 | 2004-01-01 | Armand Malnoe | Compositions and methods for detoxification and cancer prevention |
| EP1428528A1 (de) * | 2002-09-27 | 2004-06-16 | Tiense Suikerraffinaderij N.V. | Synergistische Zusammensetzungen aus Ballaststoffe und NSAID zur Behandlung von Krebs |
| FR2848783B1 (fr) * | 2002-12-18 | 2005-05-13 | Agronomique Inst Nat Rech | Utilisation de prebiotiques pour prevenir ou traiter le stress oxydant |
| US20050118234A1 (en) * | 2003-12-01 | 2005-06-02 | The Iams Company | Methods and kits related to administration of a fructooligosaccharide |
| US20050119222A1 (en) | 2003-12-01 | 2005-06-02 | The Iams Company | Compositions comprising fermentable fiber which are adapted for use by a companion animal and kits and methods of their use |
| JO3112B1 (ar) | 2010-03-29 | 2017-09-20 | Ferring Bv | تركيبة دوائية سريعة التحلل |
| KR101790188B1 (ko) * | 2010-03-29 | 2017-10-25 | 훼링 비.브이. | 속용성 약학 조성물 |
| CN105168515B (zh) * | 2015-10-19 | 2017-03-15 | 智优生物科技（上海）有限公司 | 一种利于早期癌症自愈的组合物 |
| CN107050046A (zh) * | 2017-01-24 | 2017-08-18 | 北京神州航天食品技术研究院 | 一种抗肿瘤药物 |
| GB2581531A (en) * | 2019-02-25 | 2020-08-26 | Akromaa Afolabi Bene | Deoxycholic - bound inulin |
| KR20220072855A (ko) * | 2019-09-23 | 2022-06-02 | 더 리젠츠 오브 더 유니버시티 오브 미시건 | 면역치료제 및 백신의 효율을 증가시키는 조성물 및 방법 |
| JP2022035343A (ja) * | 2020-08-20 | 2022-03-04 | 株式会社ドアーズ | がん細胞のアポトーシス促進、及び／又は、増殖抑制剤 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6089427A (ja) * | 1983-10-21 | 1985-05-20 | Dainippon Pharmaceut Co Ltd | 抗腫瘍剤 |
| JPS61231966A (ja) * | 1985-04-06 | 1986-10-16 | Nikken Food Honsha Kk | 腸内有用細菌の増殖用食品 |
| JPS6393729A (ja) * | 1986-10-09 | 1988-04-25 | Sekisui Chem Co Ltd | 悪性腫瘍等の治療方法 |
| US5422346A (en) * | 1988-01-06 | 1995-06-06 | California Natural Products | Instant dried dahlia inulin juice and its method of production and usage |
| JPH02172921A (ja) * | 1988-12-26 | 1990-07-04 | Nitto Denko Corp | 抗腫瘍剤の製造法 |
| JP2982372B2 (ja) * | 1990-03-16 | 1999-11-22 | 味の素株式会社 | ポリフラクタンを含有する飲料 |
| JP2827492B2 (ja) * | 1990-10-04 | 1998-11-25 | 味の素株式会社 | 改質フラクトースポリマーの製造法 |
| EP0692252B1 (de) * | 1994-06-14 | 2001-04-04 | "Raffinerie Tirlemontoise", société anonyme: | Verwendung einer Zusammensetzung enthaltend Inulin oder Oligofructose als Antikrebsmittel |
| US5563173A (en) * | 1994-12-22 | 1996-10-08 | Research Development Foundation | Anti-proliferative effects of sodium butyrate |
| GB9625129D0 (en) * | 1996-12-03 | 1997-01-22 | Cerestar Holding Bv | Highly fermentable resistant starch |
-
1997
- 1997-05-20 EP EP97870069A patent/EP0879600A1/de not_active Withdrawn
-
1998
- 1998-05-14 DK DK98924315T patent/DK0983072T4/da active
- 1998-05-14 US US09/424,168 patent/US6500805B2/en not_active Expired - Fee Related
- 1998-05-14 CA CA002290482A patent/CA2290482C/en not_active Expired - Fee Related
- 1998-05-14 DE DE69825887T patent/DE69825887T3/de not_active Expired - Lifetime
- 1998-05-14 ID IDW991303A patent/ID23441A/id unknown
- 1998-05-14 WO PCT/EP1998/002864 patent/WO1998052578A1/en not_active Ceased
- 1998-05-14 CN CNB988051273A patent/CN1177593C/zh not_active Expired - Fee Related
- 1998-05-14 ES ES98924315T patent/ES2223130T5/es not_active Expired - Lifetime
- 1998-05-14 AT AT98924315T patent/ATE274349T1/de not_active IP Right Cessation
- 1998-05-14 JP JP54992298A patent/JP2001526671A/ja active Pending
- 1998-05-14 EP EP98924315A patent/EP0983072B2/de not_active Expired - Lifetime
- 1998-05-14 KR KR10-1999-7010687A patent/KR100529271B1/ko not_active Expired - Fee Related
- 1998-05-14 AU AU76548/98A patent/AU7654898A/en not_active Abandoned
-
2009
- 2009-02-04 JP JP2009023494A patent/JP2009275028A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR100529271B1 (ko) | 2005-11-17 |
| EP0983072A1 (de) | 2000-03-08 |
| DE69825887T2 (de) | 2005-09-08 |
| ES2223130T5 (es) | 2009-01-16 |
| CN1177593C (zh) | 2004-12-01 |
| ID23441A (id) | 2000-04-20 |
| DK0983072T4 (da) | 2008-09-22 |
| AU7654898A (en) | 1998-12-11 |
| CN1255855A (zh) | 2000-06-07 |
| CA2290482A1 (en) | 1998-11-26 |
| KR20010012726A (ko) | 2001-02-26 |
| DE69825887T3 (de) | 2009-10-08 |
| JP2001526671A (ja) | 2001-12-18 |
| CA2290482C (en) | 2005-03-08 |
| DK0983072T3 (da) | 2004-12-06 |
| EP0983072B2 (de) | 2008-07-16 |
| JP2009275028A (ja) | 2009-11-26 |
| ES2223130T3 (es) | 2005-02-16 |
| EP0879600A1 (de) | 1998-11-25 |
| DE69825887D1 (de) | 2004-09-30 |
| EP0983072B1 (de) | 2004-08-25 |
| US20020177561A1 (en) | 2002-11-28 |
| WO1998052578A1 (en) | 1998-11-26 |
| US6500805B2 (en) | 2002-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE274349T1 (de) | Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs | |
| DE69636343D1 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
| DE69636085D1 (de) | Verwendung von gamma-Linolensäure oder Dihomogammalinolensäure zur Herstellung eines Medikaments zur Behandlung von Huntington's Chorea | |
| ATE205086T1 (de) | Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit | |
| ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
| ATE330593T1 (de) | Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen | |
| ATE127342T1 (de) | Verwendung von modafinil zur herstellung eines antiischämischen arzneimittels. | |
| LV10924A (lv) | Sintetiskie katalitiskie brivo radikalu akceptori kurus izmanto ka antioksidantus slimibu profilaksei un arstesanai | |
| ATE446101T1 (de) | Verwendung von docosahexaensäure zur herstellung eines arzneimittels zur behandlung der senilen demenz und alzheimer-erkrankung | |
| DE59006880D1 (de) | Gerät zur Herstellung von Formkörpern und Verwendung desselben zur Herstellung von Inlays, Onlays, und Kronen in der Zahnmedizin. | |
| FR2713635B1 (fr) | Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations. | |
| ATE234615T1 (de) | Verwendung von acetylcystein zur herstellung eines arzneimittels zur behandlung von chronischen geschwüren | |
| ATE219670T1 (de) | Verwendung von arachidonsäure und/oder docohexaensäure zur herstellung eines arzneimittels zur behandlung von dyspraxia | |
| ATE269077T1 (de) | Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen | |
| ATE274916T1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome | |
| DE68911891D1 (de) | Verwendung von Acetyl-L-carnitin zur Behandlung von Katarakt, sowie pharmazeutische Zusammensetzungen für eine derartige Behandlung. | |
| DE69921662D1 (de) | Verwendung von gingko biloba extrakten zur herstellung eines arzneimittels zur behandlung der amyotrophen lateralsklerose | |
| FR2713640B1 (fr) | Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations. | |
| DE3850778D1 (de) | Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks. | |
| ATE303819T1 (de) | Verwendung von langem pentraxin ptx3 zur herstellung eines arzneimittels zur verhütung und heilung von autoimmunkrankheiten | |
| DE69716341D1 (de) | Verwendung von Alkanoyl-L-Carnitinen zur Herstellung eines Arzneimittels zur Behandlung von entzündlichen Darmerkrankungen | |
| DE69733169D1 (de) | Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs | |
| DE69424563D1 (de) | Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis | |
| ATE136465T1 (de) | Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis | |
| DE59304087D1 (de) | Placentaextrakt und Verfahren zu seiner Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |